In contrast to these three studies, Hines and colleagues (2000), who evaluated 465 breast cancer patients and 621 control subjects participating in the Nurses’ Health Study, did not find any effect of ADH1C polymorphism on breast cancer risk. However, this study included women with relatively low weekly alcohol consumption, which may not result in sufficiently high acetaldehyde concentrations.
